(S1 (S (NP (NP (NN Disruption)) (PP (IN of) (NP (NN CFTR) (NN activity)))) (VP (VBZ does) (RB not) (VP (VB increase) (NP (NP (NN IL-1beta) (NN production)) (PP (IN in) (NP (NP (NNS PBMCs)) (CC and) (NP (NN THP-1) (NNS cells)))))))))
(S1 (S (S (NP (DT A) (JJ previous) (NN study)) (VP (VBZ has) (VP (VBN indicated) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN chloride) (NN ion) (NN concentration))) (PP (IN in) (NP (NP (NN suppression)) (PP (IN of) (NP (NN NLRP3) (NN inflammasome) (NN activation)))))) (PRN (-LRB- -LSB-) (NP (CD 34)) (-RRB- -RSB-))))) (. .)))
(S1 (S (S (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP (NN CFTR) (NN dysfunction)) (VP (VBZ alters) (NP (NN IL-1beta) (NN production)))))))) (, ,) (NP (NP (NP (NN THP-1) (NNS cells)) (CC and) (NP (NNS PBMCs))) (PP (IN from) (NP (NP (NN CF) (NNS patients)) (CC and) (NP (JJ healthy) (NNS controls))))) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (DT the) (NN CFTR) (NN inhibitor)) (, ,) (NP (NN CFTRinh172)) (, ,))) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NN simulation)))) (PP (IN with) (NP (JJ live) (FW P.) (FW aeruginosa))))) (. .)))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NN CFTRinh172)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NN IL-1beta) (CC or) (NN IL-8) (NN production)) (PP (IN in) (NP (NP (JJ control) (NNS subjects)) (CC or) (NP (NP (NN CF) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 8a-b)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (ADVP (RB Similarly)) (, ,) (NP (NN IL-1beta) (NN production)) (VP (VBD was) (RB not) (ADJP (JJ different)) (PP (IN in) (NP (NP (JJ monocyte-derived) (NNS macrophages)) (CC or) (NP (NP (NN THP-1) (NN reporter) (NNS cells)) (VP (VBN treated) (PP (IN with) (NP (NP (NNP CFTRinh172)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 8c-d)) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (S (NP (NP (NP (NN IL-8)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 8e)) (-RRB- -RRB-))) (CC and) (NP (NP (NN NF-kappaB) (NN activity)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 8f)) (-RRB- -RRB-)))) (VP (VBD were) (ADVP (RB also)) (ADJP (JJ unchanged) (PP (IN in) (NP (JJ CFTRinh172-treated) (NN THP-1) (NN reporter) (NNS cells)))))) (. .)))
